Mohammad H. Alyami

579 total citations
32 papers, 365 citations indexed

About

Mohammad H. Alyami is a scholar working on Pharmaceutical Science, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammad H. Alyami has authored 32 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammad H. Alyami's work include Advanced Drug Delivery Systems (4 papers), Advancements in Transdermal Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Mohammad H. Alyami is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Advancements in Transdermal Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Mohammad H. Alyami collaborates with scholars based in Saudi Arabia, Jordan and Egypt. Mohammad H. Alyami's co-authors include Hamad S. Alyami, Abdallah Y. Naser, Mohammad F. Bayan, Mohamed A. A. Orabi, Hassan Alwafi, Balakumar Chandrasekaran, Eman Zmaily Dahmash, Abdul Aleem Mohammed, Dalia Khalil Ali and Mohammad Zaki Ahmad and has published in prestigious journals such as Molecules, Sensors and RSC Advances.

In The Last Decade

Mohammad H. Alyami

29 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad H. Alyami Saudi Arabia 12 88 49 43 38 36 32 365
Muhammad Naeem Aamir Pakistan 16 223 2.5× 46 0.9× 28 0.7× 66 1.7× 38 1.1× 51 582
Hazrina Ab. Hadi Malaysia 14 72 0.8× 45 0.9× 83 1.9× 69 1.8× 39 1.1× 41 757
Adawiyah Jamil Malaysia 15 99 1.1× 25 0.5× 32 0.7× 21 0.6× 19 0.5× 52 718
Virginia Melis Spain 7 114 1.3× 214 4.4× 39 0.9× 40 1.1× 21 0.6× 7 537
Majed A. Algarni Saudi Arabia 11 54 0.6× 24 0.5× 40 0.9× 62 1.6× 73 2.0× 47 452
Tarek Mohamed Ali Elsayed Malaysia 10 37 0.4× 32 0.7× 43 1.0× 25 0.7× 21 0.6× 28 330
Taher Hatahet United Kingdom 9 263 3.0× 19 0.4× 63 1.5× 60 1.6× 55 1.5× 26 588
Van De Tran Vietnam 11 23 0.3× 48 1.0× 23 0.5× 64 1.7× 21 0.6× 68 411
Dorota Bielska Poland 11 113 1.3× 31 0.6× 51 1.2× 122 3.2× 40 1.1× 30 538
Akhilesh Dubey India 13 269 3.1× 18 0.4× 70 1.6× 66 1.7× 32 0.9× 51 588

Countries citing papers authored by Mohammad H. Alyami

Since Specialization
Citations

This map shows the geographic impact of Mohammad H. Alyami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad H. Alyami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad H. Alyami more than expected).

Fields of papers citing papers by Mohammad H. Alyami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad H. Alyami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad H. Alyami. The network helps show where Mohammad H. Alyami may publish in the future.

Co-authorship network of co-authors of Mohammad H. Alyami

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad H. Alyami. A scholar is included among the top collaborators of Mohammad H. Alyami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad H. Alyami. Mohammad H. Alyami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beigh, Saba, et al.. (2025). Ginkgolide as a Promising Multi-Target Therapeutic for Alzheimer's Disease: Targeting ApoE4 and Beyond. Current Pharmaceutical Design. 32(15). 1200–1213.
3.
Alyami, Mohammad H., et al.. (2025). Advances in lipid-based nanoformulations for inhaled antibiotic therapy in respiratory infections. Drug Discovery Today. 30(6). 104380–104380. 4 indexed citations
4.
Alyami, Mohammad H., et al.. (2024). The Prevalence of Risk Factors for Cardiovascular Diseases in Najran Region, Saudi Arabia. Journal of Personalized Medicine. 14(5). 470–470.
5.
El‐Shiekh, Riham A., Mohamed Y. Mahmoud, Heba M. A. Khalil, et al.. (2024). Efficacy of Quercetin and Quercetin Loaded Chitosan Nanoparticles Against Cisplatin-Induced Renal and Testicular Toxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals. 17(10). 1384–1384. 5 indexed citations
6.
Bayan, Mohammad F., Balakumar Chandrasekaran, & Mohammad H. Alyami. (2023). Development and Characterization of Econazole Topical Gel. Gels. 9(12). 929–929. 19 indexed citations
7.
Alyami, Hamad S., et al.. (2023). Drug shortages in Najran region, Saudi Arabia: A cross-sectional survey. Clinical Epidemiology and Global Health. 21. 101305–101305. 3 indexed citations
8.
Alyami, Mohammad H., et al.. (2023). Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems. ADMET & DMPK. 12(1). 167–176. 1 indexed citations
9.
Alyami, Hamad S., Dalia Khalil Ali, Qais Jarrar, et al.. (2023). Taste Masking of Promethazine Hydrochloride Using l-Arginine Polyamide-Based Nanocapsules. Molecules. 28(2). 748–748. 11 indexed citations
10.
Alyami, Mohammad H., et al.. (2023). Prevalence and Knowledge of Respiratory Symptoms Among the General Public in the Southern Area of Najran, Saudi Arabia: A Cross-Sectional Health Survey Study. International Journal of General Medicine. Volume 16. 4077–4090. 2 indexed citations
13.
Alyami, Mohammad H., et al.. (2023). Development of a Polyherbal Topical Gel for the Treatment of Acne. Gels. 9(2). 163–163. 15 indexed citations
15.
Dahmash, Eman Zmaily, et al.. (2022). Novel Thymoquinone Nanoparticles Using Poly(ester amide) Based on L-Arginine-Targeting Pulmonary Drug Delivery. Polymers. 14(6). 1082–1082. 20 indexed citations
16.
Bayan, Mohammad F., et al.. (2022). Smart Pellets for Controlled Delivery of 5-Fluorouracil. Molecules. 28(1). 306–306. 14 indexed citations
17.
Algahtani, Mohammed S., Mohammad Zaki Ahmad, Hassan A. Albarqi, et al.. (2021). Preparation and Characterization of Curcumin Nanoemulgel Utilizing Ultrasonication Technique for Wound Healing: In Vitro, Ex Vivo, and In Vivo Evaluation. Gels. 7(4). 213–213. 60 indexed citations
18.
Alyami, Hamad S., et al.. (2021). Clinical and Therapeutic Characteristics of Cancer Patients in the Southern Region of Saudi Arabia: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 18(12). 6654–6654. 2 indexed citations
19.
Alyami, Hamad S., et al.. (2020). Characterization and evaluation of the performance of starch and cellulose as excipients for direct compression technique. Tropical Journal of Pharmaceutical Research. 19(8). 1569–1576. 2 indexed citations
20.
Alyami, Mohammad H., Abdallah Y. Naser, Mohamed A. A. Orabi, Hassan Alwafi, & Hamad S. Alyami. (2020). Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study. Frontiers in Public Health. 8. 506–506. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026